СПОРНЫЕ МЕТОДЫ ЛЕЧЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА
Аннотация
Об авторе
И. В. СамородскаяРоссия
Самородская Ирина Владимировна.
117334, Москва, Петроверигский переулок, д.10, +7 (985) 224-60-50
Список литературы
1. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза Российские рекомендации V пересмотр. Москва; 2012. Режим доступа: http://www.scardio.ru/content/Guidelines/rek_lipid_2012. pdf. [Diagnostika i korrekcija narushenij lipidnogo obmena s cel’ju profilaktiki i lechenija ateroskleroza Rossijskie rekomendacii V peresmotr. Moscow; 2012.Available from:http://www.scardio.ru/content/Guidelines/rek_lipid_2012.pdf. (In Russ)].
2. Диагностика и лечение хронической ишемической болезни сердца. Клинические рекомендации Общества специалистов по неотложной кардиологии. 2013. http://medi.ru/doc/a030923.htm. [Diagnostika i lechenie hronicheskoj ishemicheskoj bolezni serdca. Klinicheskie rekomendacii Obshhestva specialistov po neotlozhnoj kardiologii. Available from: http://medi.ru/doc/a030923.htm. (In Russ)].
3. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P. et alJ. Am. Coll. Cardiol. 2012 Dec 18; 60(24): e44-e164. 2014 ACC/AHA/ AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. Circulation. 2014;130:1749-1767.)D0I: 10.1016/j.jacc.2012.07.013.
4. 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDC-cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease RiskA Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents J. Am. Coll. Cardiol. 2016; 68: 92-125 http:// content.onlinejacc.org/article.aspx?articleid=2510936&_ga=1.242276683.831055067.1428269375. doi: 10.1016/j.jacc.2016.03.519.
5. Goblirsch G., Bershow S., Cummings K., Hayes R., Kokoszka M., Lu Y. et al. Stable coronary artery disease. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2013 May. 71 p. [98 references]
6. University of Michigan Health System. Secondary prevention of ischemic heart disease and stroke in adults. Ann Arbor (MI): University of Michigan Health System; 2014 May. 23 p. [83 references]
7. 2013 ESC guidelines on the management of stable coronary artery disease. Eur. Heart J. 2013 0ct;34(38):2949-3003. DOI: 10.1093/eurheartj/eht296
8. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention& Rehabilitation (EACPR). Eur. J. Prev. Cardiol. 2016 Jul.; 23(11):NP1-NP96. DOI: 10.1177/2047487316653709
9. Stable angina: management. NICE Clinical guideline [CG126] Last updated: August 2016 https://www.nice.org.uk/guidance/cg126/chapter/1-Guidance#anti-anginal-drug-treatment.
10. Cardiovascular disease: risk assessment and reduction, including lipid modification. NICE guidelines [CG181] Published date: July 2014 Last updated: July 2016 https://www.nice.org.uk/guidance/cg181/chapter/Changes-after-publication.
11. Mc Gillion M., Arthur H.M., Cook A., Carroll S.L., Victor J.C., LAllier P.L. et al Canadian Cardiovascular Society, Canadian Pain Society. Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines. Can. J. Cardiol. 2012 Mar-Apr; 28 (2 Suppl.): S20-41.doi:10.1016/j.cjca.2011.07.007.
12. Mancini John G. B., Gosselin G., Chow B., Kostuk W., Stone J., Yvorchuk K. J. et al. Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart disease. Can. J. Cardiol. 2014 Aug 28; 30(8): 837-49. doi: 10.1016/j.cjca.2014.05.013
13. 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. http://dx.doi.org/10.1016/j.cjca.2016.07.510
14. Hypercholesterolemia mipomersen [ID524] https://www.nice.org.uk/guidance/indevelopment/gid-tag437
15. Кардиология: Национальное руководство. ред. Ю.Н. Беленков, Р.Г. Оганов. М: ГЭОТАР-Медиа, 2010. p. 1232 [Kardiologija: Nacional’noe rukovodstvo. red. Ju.N. Belenkov, R.G. Oganov. Moscow: GJeOTAR-Media; 2010. 1232. (InRuss)].
16. Самородская И.В. Мельдоний: обзор результатов исследований. РМЖ. 2013; 36: 1818. [Samorodskaya I.V. Mel’donij: obzor rezul’tatov issledovanij. RMZh. 2013; 36:1818. (In Russ)].
17. Schobersberger W., Dunnwald T., Gmeiner G., Blan C. Story behind meldonium-from pharmacology to performance enhancement: a narrative review. Br J Sports Med. 2017; 51(1):22-25 doi: 10.1136/bjsports-2016-096357. Epub 2016 Jul 27.
18. Gorski D. H., Novella S. P. Clinical trials of integrative medicine: testing whether magic works? Trends in Molecular Medicine. 2014; 20 (9): 473-476. DOI: http://dx.doi.org/10.1016/j.molmed.2014.06.007
19. Wei Liu, Xingjiang Xiong, Xiaochen Yang, Fuyong Chu, Hongxu Liu The Effect of Chinese Herbal Medicine Gualouxiebaibanxia Decoction for the Treatment of Angina Pectoris: A Systematic Review. Evidence-Based Complementary and Alternative Medicine. 2016; 2016 : Article ID 8565907. http://dx.doi.org/10.1155/2016/8565907.
Рецензия
Для цитирования:
Самородская И.В. СПОРНЫЕ МЕТОДЫ ЛЕЧЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА. Комплексные проблемы сердечно-сосудистых заболеваний. 2017;6(4):112-120. https://doi.org/10.17802/2306-1278-2017-6-4-112-120
For citation:
Samorodskaya I.V. CONTROVERSIAL ISSUES IN THE TREATMENT OF CORONARY ARTERY DISEASE. Complex Issues of Cardiovascular Diseases. 2017;6(4):112-120. (In Russ.) https://doi.org/10.17802/2306-1278-2017-6-4-112-120